Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis

WHO first recognised extranodal NK/T-cell lymphoma (ENKTCL) in 2001, thanks to technical advances in anatomopathology and immunohistochemistry. It is divided into nasal and extranasal subgroups depending on the primary site. Primary isolated NK/T-cell lymphoma of the testis is rare. Typical recurrence sites of primary testicular NK/T-cell lymphoma are the gastrointestinal tract, lymph nodes, skin, spleen and central nervous system. Nasal relapses of a primary NK/T-cell lymphoma of the testis are very rare and according to our knowledge, no other case has been reported yet in the literature. The authors report the case of a 35-year-old Caucasian man relapsing twice in the nasal cavity 1 year after initial diagnosis and treatment of a primary isolated, stage IE, ENKTCL of the testis. We report the clinical and radiological presentation of the nasal relapses and the different modalities of treatment that were applied. Sinonasal relapses of an isolated primary NK/T-cell lymphoma of the testis are very rare. ENKTCL is a very aggressive entity, even at an early stage, therefore, requiring a multimodal treatment approach including chemotherapy and radiotherapy. New strategies to treat this disease are needed.

[1]  J. Yun,et al.  De Novo Testicular Extranodal NK/T-Cell Lymphoma: A Clinicopathologic Study of 21 Cases With Review of Additional 18 Cases in the Literature , 2019, The American journal of surgical pathology.

[2]  L. Shih,et al.  Extranodal NK/T‐cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases , 2018, European journal of haematology.

[3]  J. Armitage,et al.  Natural Killer/T‐cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States , 2018, Clinical lymphoma, myeloma & leukemia.

[4]  Jeremy D. Clark,et al.  CD56 Negative Extranodal NK/T-cell Lymphoma of the Orbit Mimicking Orbital Cellulitis , 2013, Orbit.

[5]  Qun-pei Yang,et al.  Extranodal nasal type natural killer/T-cell lymphoma of testis: report of seven cases with review of literature , 2012, Leukemia & lymphoma.

[6]  Y. Ko,et al.  When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type? , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  C. Barrionuevo,et al.  Extranodal NK/T-cell Lymphoma, Nasal Type: Study of Clinicopathologic and Prognosis Factors in a Series of 78 Cases From Peru , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[8]  L. Shih,et al.  Nasal NK/T Cell Lymphoma in Taiwan: A Clinicopathologic Study of 22 Cases, with Analysis of Histologic Subtypes, Epstein-Barr Virus LMP-1 Gene Association, and Treatment Modalities , 2004, International journal of surgical pathology.

[9]  W. Au,et al.  Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. , 2004, Blood.

[10]  P. Koduru,et al.  Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity. , 1993, The American journal of surgical pathology.

[11]  D. Utz,et al.  Lymphoma of the testis , 1970, Cancer.